Markets

Champions Oncology (CSBR) Soars: Stock Adds 10.7% in Session

Champions Oncology, Inc.CSBR was a big mover last session, as the company saw its shares rise nearly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $8.20-$17.47 in the past one-month time frame, showed a sharp increase yesterday.

The company has seen one positive estimate revision in the past month, while its Zacks Consensus Estimate for the current quarter has also moved higher over the same time frame, suggesting that more solid trading could be ahead for Champions Oncology. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Champions Oncology currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.

Champions Oncology, Inc. Price

Champions Oncology, Inc. Price | Champions Oncology, Inc. Quote

Another stock worth considering in the Medical - Drugs industry is BioSpecifics Technologies Corp. BSTC which also carries a Zacks Rank #1. You can see the complete list of today's Zacks #1 Rank stocks here .

Is CSBR going up? Or down? Predict to see what others think: Up or Down

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Champions Oncology, Inc. (CSBR): Free Stock Analysis Report

BioSpecifics Technologies Corp (BSTC): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

BSTC CSBR

Other Topics

Investing Stocks